MedCap AB (publ) Cash Flow Conversion Efficiency
MedCap AB (publ) cash flow conversion efficiency. Based on the latest financial reports, MedCap AB (publ) (MCAP) has a cash flow conversion efficiency ratio of 0.034x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr51.70 Million ≈ $5.56 Million USD) by net assets (Skr1.53 Billion ≈ $164.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of MedCap AB (publ) (2007–2025)
Cash flow conversion efficiency of MedCap AB (publ) from 2007 to 2025. This chart illustrates how MedCap AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for MedCap AB (publ) for real-time trading data and today's change.
MedCap AB (publ) Cash Flow Conversion Ratio Explained
MedCap AB (publ) cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
MedCap AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MedCap AB (publ) ranked by their cash flow conversion efficiency. Also see MCAP market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Foxsemicon Integrated Technology Inc
TW:3413
|
-0.012x |
|
Aktia Bank Abp
HE:AKTIA
|
-0.058x |
|
Fiyta Holdings Ltd
SHE:000026
|
0.050x |
|
NGERN TID LOR-NVDR- BA37
F:70V0
|
N/A |
|
Irish Continental Group PLC
IR:IR5B
|
0.070x |
|
GSK plc
LSE:GSK
|
0.147x |
|
Sparebanken Sor
OL:SOR
|
0.095x |
|
Hyundai Wia
KO:011210
|
-0.019x |
Annual Cash Flow Conversion Efficiency for MedCap AB (publ) (2007–2025)
The table below shows the annual cash flow conversion efficiency of MedCap AB (publ) from 2007 to 2025. Review MedCap AB (publ) free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr1.46 Billion ≈ $157.00 Million |
Skr342.70 Million ≈ $36.88 Million |
0.235x | -15.94% |
| 2024-12-31 | Skr1.29 Billion ≈ $138.63 Million |
Skr360.00 Million ≈ $38.74 Million |
0.279x | +25.89% |
| 2023-12-31 | Skr1.03 Billion ≈ $110.53 Million |
Skr228.00 Million ≈ $24.54 Million |
0.222x | +122.94% |
| 2022-12-31 | Skr858.70 Million ≈ $92.41 Million |
Skr85.50 Million ≈ $9.20 Million |
0.100x | -40.27% |
| 2021-12-31 | Skr697.70 Million ≈ $75.08 Million |
Skr116.30 Million ≈ $12.52 Million |
0.167x | -13.19% |
| 2020-12-31 | Skr602.00 Million ≈ $64.78 Million |
Skr115.60 Million ≈ $12.44 Million |
0.192x | -10.50% |
| 2019-12-31 | Skr332.80 Million ≈ $35.81 Million |
Skr71.40 Million ≈ $7.68 Million |
0.215x | -35.16% |
| 2018-12-31 | Skr273.80 Million ≈ $29.47 Million |
Skr90.60 Million ≈ $9.75 Million |
0.331x | +224.47% |
| 2017-12-31 | Skr267.70 Million ≈ $28.81 Million |
Skr27.30 Million ≈ $2.94 Million |
0.102x | -63.41% |
| 2016-12-31 | Skr292.29 Million ≈ $31.45 Million |
Skr81.46 Million ≈ $8.77 Million |
0.279x | +675.70% |
| 2015-12-31 | Skr308.15 Million ≈ $33.16 Million |
Skr-14.92 Million ≈ $-1.61 Million |
-0.048x | -701.63% |
| 2014-12-31 | Skr280.63 Million ≈ $30.20 Million |
Skr2.26 Million ≈ $243.00K |
0.008x | +106.43% |
| 2013-12-31 | Skr221.92 Million ≈ $23.88 Million |
Skr865.00K ≈ $93.09K |
0.004x | -98.02% |
| 2012-12-31 | Skr195.48 Million ≈ $21.04 Million |
Skr38.55 Million ≈ $4.15 Million |
0.197x | +16.49% |
| 2011-12-31 | Skr169.82 Million ≈ $18.28 Million |
Skr28.75 Million ≈ $3.09 Million |
0.169x | -0.54% |
| 2010-12-31 | Skr179.99 Million ≈ $19.37 Million |
Skr30.64 Million ≈ $3.30 Million |
0.170x | +67.04% |
| 2009-12-31 | Skr169.94 Million ≈ $18.29 Million |
Skr17.32 Million ≈ $1.86 Million |
0.102x | +305.17% |
| 2008-12-31 | Skr134.11 Million ≈ $14.43 Million |
Skr3.37 Million ≈ $362.99K |
0.025x | +49.35% |
| 2007-12-31 | Skr127.44 Million ≈ $13.71 Million |
Skr2.15 Million ≈ $230.94K |
0.017x | -- |
About MedCap AB (publ)
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; an… Read more